The crossroads of America
Nicholas Dockery Medal of Honor Act
The bill allows a retroactive Medal of Honor to correct a past oversight and affirms DoD's authority to fix awards, trading a meaningful act of recognition and institutional fairness for a modest cost and the potential precedent of more late-award exceptions.
State Standing Committee Act
The bill gives subnational environmental agencies a formal, transparent channel to shape federal science and rulemaking — improving local input and oversight — while reducing some FACA safeguards and narrowing who can serve and who receives reports, which may limit independence and increase politicization.
BIO-SCALE Act
The bill uses significant federal funding to build public pilot-scale biomanufacturing hubs that can accelerate commercialization, local jobs, workforce training, and national-security tech transfer, but does so by excluding for-profit operators, imposing open-access/IP rules, and setting tight spending and sunset rules that create financial risk and uncertainty for some stakeholders.
FORGE Act
The bill boosts U.S. competitiveness and promotes safer, nonproliferation-focused SMR exports through diplomatic and technical support and greater transparency, but does so at increased federal cost and with longer-term security, planning, and fairness risks for taxpayers, partner governments, and industry.
Tech Diplomacy Training Act
The bill strengthens diplomats' technical skills and near-term readiness but does so by imposing new training burdens and deadlines that raise costs, risk operational strain, and could politicize curricula.
Interagency Coordination in Export Controls Act of 2026
The bill accelerates and tightens U.S. export controls to better protect national security and block PRC military access to U.S. technology, but does so by concentrating authority and compressing timelines in ways that raise compliance costs, risk rushed or politicized rules, and dilute technical and military oversight.
Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026
The bill would expand U.S. bioindustrial scale-up capacity, shared infrastructure, and regional jobs with dedicated federal funding—accelerating commercialization and supply-chain resilience—at the cost of taxpayer spending, potential private-sector partnership frictions from open-access/IP rules, governance and biosecurity risks, and possible program implementation challenges.
Hemp Planting Predictability Act
The bill delays implementation of new hemp rules by two years, giving farmers and regulators time to prepare but postponing health/safety protections and extending market uncertainty for businesses.
To amend the Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2026, to delay the implementation of amendments made by such Act to the hemp production provisions of the Agricultural Marketing Act of 1946.
The bill trades a roughly two‑year postponement of hemp rule implementation—giving growers and rural businesses more time to comply and plan—for a delay in consumer protections and continued regulatory uncertainty for markets.
Increased TSP Access Act of 2025
The bill expands and speeds use of third‑party certifiers to improve producer access and transparency, but raises fiscal costs, risks inconsistent assistance quality, and may strain administering agencies or leave small/remote producers behind.